| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/06/1992 | US5153311 Immunogenic glycoproteins of human cytomegalovirus gCII |
| 10/06/1992 | US5153129 Immunogenic purified protease extracted form malarial parasites which react with protective antibodies orginating form monkeys resistance to human parasites |
| 10/06/1992 | US5152982 Compositions and methods for FeLV vaccination |
| 10/06/1992 | US5152981 Newcastle disease virus vaccine and method for the application thereof |
| 10/04/1992 | CA2064635A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 10/02/1992 | CA2064413A1 Anti-idiotypic monoclonal antibodies |
| 10/01/1992 | WO1992016636A1 Recombinant virus vectors encoding human papillomavirus proteins |
| 10/01/1992 | WO1992016628A1 Polypeptides from mycobacterium paratuberculosis |
| 10/01/1992 | WO1992016624A1 Monoclonal antibody against lps core |
| 10/01/1992 | WO1992016621A1 Novel beta integrin subunit |
| 10/01/1992 | WO1992016619A1 Expression of influenza nucleoprotein antigens in baculovirus |
| 10/01/1992 | WO1992016616A1 Malaria recombinant poxvirus vaccine |
| 10/01/1992 | WO1992016561A1 Ovine adipocyte antigens and their use in the immunological control of fat |
| 10/01/1992 | WO1992016558A1 Cell surface receptors homologous to coagulation factors v and viii |
| 10/01/1992 | WO1992016556A1 Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 10/01/1992 | WO1992016554A1 Protein allergens of the species cynodon dactylon |
| 10/01/1992 | WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 10/01/1992 | WO1992016543A1 NORWALK VIRUS HUMAN GASTROENTERITIS AGENT AND MOLECULAR CLONING OF CORRESPONDING cDNAs |
| 10/01/1992 | WO1992016232A1 Polysaccharide-protein conjugates |
| 10/01/1992 | WO1992016231A1 HERPES SIMPLEX VACCINE COMPRISING HSV GLYCOPROTEIN gD AND 3 dEACYLATED MONOPHOSPHORYL LIPID A |
| 10/01/1992 | WO1992016223A1 Production of gonorrheal pi proteins and vaccines |
| 10/01/1992 | WO1992016203A1 Palytoxin-related prodrugs and a method for their administration |
| 10/01/1992 | WO1992004048A3 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 10/01/1992 | DE4110409A1 Neue protein-polykation-konjugate New protein-polycation conjugates |
| 10/01/1992 | CA2106464A1 Malaria recombinant poxvirus vaccine |
| 10/01/1992 | CA2106069A1 Recombinant virus vectors encoding human papillomavirus proteins |
| 10/01/1992 | CA2105993A1 Cell surface receptors homologous to coagulation factors v and viii |
| 09/30/1992 | WO1992017188A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | WO1992017187A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | EP0506651A2 Pharmaceutical preparation based on plasma proteins |
| 09/30/1992 | EP0506523A2 Monoclonal antibodies |
| 09/30/1992 | EP0506211A1 Vaccines |
| 09/30/1992 | EP0506147A2 Canine distemper virus vaccine |
| 09/30/1992 | EP0506124A1 Methods and substances for recruiting therapeutic agents to solid issues comprising two single chain VH-VL bifunctional binding molecules |
| 09/30/1992 | EP0505908A1 Chimaeric polypeptides |
| 09/30/1992 | EP0505749A2 Monoclonal antibodies directed to activated endothelial cells and their therapeutic and diagnostic use |
| 09/30/1992 | EP0505387A1 Dna binding proteins including androgen receptor |
| 09/30/1992 | EP0505357A1 Method for antibody targeting of diagnostic or therapeutic agents |
| 09/30/1992 | EP0505353A1 Fast printer with a particle trap in the paper channel. |
| 09/30/1992 | EP0307472B1 Immunogenic recombinant yeast expression product and method for purifying it |
| 09/30/1992 | CN1064892A Recombinant virus vectors |
| 09/30/1992 | CN1064891A Vaccines |
| 09/30/1992 | CA2107365A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | CA2107362A1 New non-anticoagulant heparin derivatives |
| 09/29/1992 | US5151267 Bovine herpesvirus type 1 polypeptides and vaccines |
| 09/29/1992 | US5151023 Hepatitis a,b-combined adjuvanted vaccine |
| 09/29/1992 | CA2064114A1 Somatostatin receptor |
| 09/28/1992 | CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4 |
| 09/27/1992 | WO1992017612A1 Assay for non-a non-b hepatitis |
| 09/27/1992 | CA2082924A1 Assay for non-a non-b hepatitis |
| 09/23/1992 | EP0505034A2 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom |
| 09/23/1992 | EP0504388A1 Varicella-zoster virus antigen |
| 09/23/1992 | EP0504363A1 PURIFIED IgG ANTIBODIES |
| 09/23/1992 | EP0504350A1 Antibodies directed against cd3 |
| 09/23/1992 | EP0504335A1 A fibronectin binding peptide |
| 09/23/1992 | EP0504327A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/23/1992 | EP0504305A1 Method for diagnosing neurodegenerative diseases |
| 09/23/1992 | EP0504234A1 ANTIBODIES PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS |
| 09/23/1992 | EP0504136A1 Tolerogenic immunoglobulin-protein conjugates |
| 09/23/1992 | EP0227809B1 Process and composition for treatment of cancer and non-malignant tumors |
| 09/23/1992 | CA2061507A1 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived thereform |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | WO1992016235A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | US5149786 Free of adrenal and brain derived proteins, useful for treating perkinson's disease and schizophrenia |
| 09/22/1992 | US5149782 Macromolecular drug linked to hydrophobic membrane blending agent for insertion; cleavably linked blocking agent |
| 09/22/1992 | US5149660 Diagnostic reagents relating to herpes simplex virus |
| 09/22/1992 | US5149653 By freeze-drying or drying in presence of stabilizer trehalose storage stability; used as immunogenic vaccines |
| 09/22/1992 | US5149650 Recombinant DNA, coding sequences, host cells |
| 09/22/1992 | US5149532 Transforming lactobacillus by recombinant DNA technology to express herpes virus glycoprotein D, growing lactobacillus in culture media, harvesting by separation |
| 09/22/1992 | US5149531 Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza |
| 09/22/1992 | US5149530 Live newcastle disease virus vaccines |
| 09/22/1992 | US5149529 Compositions and treatment for herpes simplex |
| 09/22/1992 | CA2105378A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | CA1307737C Use of antibody/antigen interactions entities to protect or modulatebiological activity |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/17/1992 | WO1992015885A1 Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations |
| 09/17/1992 | WO1992015699A1 High affinity humanized monoclonal antibodies |
| 09/17/1992 | WO1992015689A1 Expression of recombinant proteins in attenuated bacteria |
| 09/17/1992 | WO1992015688A1 Production of recombinant proteins |
| 09/17/1992 | WO1992015684A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
| 09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015609A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | WO1992015330A1 Method for anti-lhrh immunoneutralization for ungelded male domestic animals and peptide therefor |
| 09/17/1992 | WO1992015328A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 09/17/1992 | WO1992015325A1 Solomon islands variants of human t-lymphotropic virus |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/17/1992 | CA2105863A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | WO1992016230A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | EP0503916A1 Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503505A1 Purified mite allergen |
| 09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
| 09/16/1992 | EP0503293A1 Specific chicken egg antibody and method for its production |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | EP0503055A1 Inhibitor of lymphocyte response and immune-related disease |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | EP0245520B1 Monoclonal antibody against glutathione s-transferase and its use in the diagnosis of cancer |